# Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patients

> **NIH NIH OT2** · BOSTON CHILDREN'S HOSPITAL · 2021 · $886,788

## Abstract

No abstract provided

## Key facts

- **NIH application ID:** 10317505
- **Project number:** 3OT2HL154984-01S1
- **Recipient organization:** BOSTON CHILDREN'S HOSPITAL
- **Principal Investigator:** Daniel Evan Bauer
- **Activity code:** OT2 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $886,788
- **Award type:** 3
- **Project period:** 2020-06-18 → 2022-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10317505

## Citation

> US National Institutes of Health, RePORTER application 10317505, Therapeutic BCL11A enhancer gene editing to induce fetal hemoglobin in β-hemoglobinopathy patients (3OT2HL154984-01S1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10317505. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*